Latest News

ETAP-Lab will participate on June 14 & 15 to NutrEvent in Lille. Contact us for scheduling a meeting there with Pascale ROZAN or Jean-François BISSON. Join us to our stand For more information about this meeting click here.

Dr Nicolas VIOLLE is the executive partner of STROK@LLIANCE, the new preclinical platform resulting from the alliance of the public Experimental Stroke Research Platform (ESRP; Université de Caen Normandie) and the well-established French private CRO, ETAP-Lab. He will participate to ESOC 2017 in order to meet players in the pharmaceutical industry and to promote STROK@LLIANCE the only CRO 100% dedicated to Preclinical Stroke Research. Contact :contact@strokalliance.com

This year conferences of AFSTAL will focus on Ethology in Animal Experimentation, that is one of the main concerns of our company.

In order to strenghten its leading position on preclinical expertise in the field of Dermatology, ETAP-Lab finalizes the development of a model of atopic dermatitis in BALB/c mice using the chemical agent DNCB. This model will shortly be added to ETAP-Lab’s catalog in order to test new active compounds against this pathology. For more information please contact us.

Join us at Hi Europe & Ni Hi Europe &Ni promises you a complete 360 degree perspective of the nutrition and health ingredients industry through an exclusive offering of new ingredients & solutions, innovative tours, presentations & live demonstrations. We are in Frankfurt from 29 November – 1 December and would like to invite you to our booth! WE’LL BE WAITING FOR YOU AT STAND F48-5 We will showcase our latest innovations and our team will be ready to meet you face-to-face.. We look forward to

DERMATOLOGY : ETAP-Lab's preclinical results obtained for PiLeJe will be presented in a poster “Identification of two probiotic strains able to prevent skin inflammation in a murine model” at the 4th World Congress on Targeting Microbiota, October 17-19, 2016, Institut Pasteur, Paris (France). Congress Website PiLeJe Website

ETAP-Lab is pleased to announce a 12-month collaboration with the MIRCen imaging platform directed by Pr. Philippe Hantraye(French Atomic Energy Commission (CEA), Fontenay-aux-Roses, France). This collaboration is happening within the context of a specific project aimed at supporting the translation of an innovative drug for acute ischemic stroke from preclinic to clinic. ETAP-Lab is contributing its original thrombo-embolic stroke model in rats, while MIRCen brings its outstanding expertise in the field of MRI in rodents. Stroke is one of the most prevalent life-threatening conditions in

CEN Nutriment and ETAP-Lab are pleased to announce they go into partnership to propose a global advice and service offer aimed at allowing their clients to meet EFSA requirement regarding scientific files for Health-Claims. ETAP-Lab proposes a large scale of preclinical trials to assess the safety and efficacy of products with potential health benefits. CEN Nutriment attains the next milestone by developing and performing clinical trial and observational studies to evaluate health claims of these products. The complementary experience shared by both societies allows to elaborate

ETAP has signed several toxicity contracts including a sub chronical 90-days study by oral administration and two other contracts are already in discussion.

Publication of a new article co-written by ETAP-Lab in the field of Visceral Pain: “Benefits of preventive administration of Chlorella sp. on visceral pain and cystitis induced by a single administration of cyclophosphamide in female Wistar rat”, Journal of Medicinal Food 19(5):450-6, 2016